Interventional oncology market size was valued at $1,984.00 million in 2021 and is projected to reach $4,127.21 million by 2031, registering a CAGR of 7.6% from 2022 to 2031. Interventional oncology (IO) is a modern oncology branch which is used in the treatment of cancer by using magnetic resonance imaging (MRI), ultrasounds, computed tomography (CT), and X-rays, for guiding other devices like ablation electrodes.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
The report provides a comprehensive analysis of the key players that operate in the global interventional oncology market. The key companies profiled in the report include Alpinion Medical Systems Co. Ltd., Teleflex Incorporated, Siemens Healthineers, Hologic, Inc., Boston Scientific, Medtronic, Profound Medical, Terumo Corporation, AngioDynamics, and Merit Medical.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/3702
Interventional oncology therapies are very beneficial for the patients as these therapies are minimally invasive, have lesser time for the recovery, have very few side effects as compared to other treatments, and involves lesser discomfort. Some of the interventional oncology operations can also be performed as an outpatient procedure, which allows the patient for earlier discharge which frees up hospital beds and lowers expenses, and this is expected to drive market growth. Nowadays, interventional oncology is considered as an important component in the field of modern oncology care, cancer treatment, supporting numerous surgical, medical, and radiation oncology therapies.
Rise in the volume of patients who are suffering from liver, breast, lung and other types of cancer, surge in the preferences towards minimally invasive procedures, rise in the prevalence of target and geriatric population, along with the rising levels of government support for interventional oncology and public-private funding, rise in the number of technological advancements are prevailing the growth of the interventional oncology market. Moreover, increasing number of applications from developing countries and rise in the number of hospitals which will further contribute by generating massive opportunities which are leading to the growth of the market. Along with this, the key players in the market are increasingly focusing on launching novel technologically advanced products.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/3702
By product, the particle embolization segment generated the highest revenue in the interventional oncology market in 2021 owing to growing demand of embolization particles for interventional oncology, key players who are introducing new and technologically advanced products with improved efficiency, and favorable reimbursement scenario.
By region, North America accounted for the largest market share in the interventional oncology devices market in 2021 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to rising cases of chronic cancer such as lung cancer, hepatocellular carcinoma, metastatic colorectal cancer, and renal cancer, in this region. Along with this, rise in the rate of adoption of minimally invasive surgeries during the treatment of cancer along with other technologically advanced interventional oncology products and well-established healthcare infrastructure.
Asia-Pacific witnessed the highest growth rate for the interventional oncology market and is expected to continue this trend throughout the forecast period, which is attributed to the efforts taken up by the government to increase the funding for oncological treatments. Moreover, commercialization of advanced interventional procedures and products along with the supportive regulations for development of these products, rising healthcare expenditure, and expansion of the research bases in countries like China, Japan, and India.
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
- By product, the particle embolization segment currently dominates the global interventional oncology market and this trend is anticipated to continue during the forecast period owing to growing demand of embolization particles for interventional oncology and interventional cardiovascular procedure, and favorable reimbursement scenario.
- On the basis of region, in 2021, North America dominated the market, owing to increasing expenditure on various cancer-related treatments and rise in the number of various state-of-the-art cancer care centers. However, Asia-Pacific is expected to witness considerable market growth during the forecast period due to its efforts taken up by the government to increase the funding for oncological treatments, commercialization of advanced interventional procedures and products along with the supportive regulations for development of these products, rising healthcare expenditure, and expansion of the research bases in countries like China, Japan, and India are fueling the growth of the market in this region.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.